DRUG: AVM0703
DRUG: Fludarabine
RADIATION: Total-Body Irradiation
PROCEDURE: Donor Lymphocyte Infusion
DRUG: Cyclophosphamide
DRUG: Tacrolimus
DRUG: Mycophenolate Mofetil
PROCEDURE: Hematopoietic Cell Transplantation
DRUG: Melphalan
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Diagnostic Imaging
PROCEDURE: Biospecimen Collection
PROCEDURE: Biospecimen Collection
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
PROCEDURE: Computed Tomography
RADIATION: External Beam Radiation Therapy
PROCEDURE: Leukapheresis
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
DRUG: Polatuzumab Vedotin
BIOLOGICAL: Rituximab
DRUG: Prednisone
DRUG: Etoposide
DRUG: Doxorubicin
DRUG: Cyclophosphamide
BIOLOGICAL: Glofitamab
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Echocardiography
PROCEDURE: FDG-Positron Emission Tomography
PROCEDURE: Computed Tomography
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
DIAGNOSTIC_TEST: NGS-MRD
DRUG: Myeloablative allogeneic HCT with a non-TBI conditioning regimen
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
BIOLOGICAL: Rituximab
BIOLOGICAL: 19-28z/IL-18 CAR T cells
BIOLOGICAL: CD19x22 CAR T
BIOLOGICAL: EBV-specific T cells: A
BIOLOGICAL: EBV-specific T cells: B
BIOLOGICAL: zamtocabtagene autoleucel (MB-CART2019.1)
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Bendamustine
DRUG: VIP943
DRUG: Mogamulizumab
DRUG: Brentuximab vedotin
DEVICE: Alpha/Beta T-cell and B-cell depleted HCT
DRUG: Blinatumomab
DRUG: Oral repotrectinib (TPX-0005)
DRUG: ONO-4685
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Dual-Energy Computed Tomography
PROCEDURE: Echocardiography
DRUG: Fludarabine
PROCEDURE: Magnetic Resonance Imaging
DRUG: Melphalan
PROCEDURE: Multigated Acquisition Scan
BIOLOGICAL: Partially Engineered T-regulatory Cell Donor Graft TRGFT-201
DRUG: Tacrolimus
DRUG: Thiotepa
RADIATION: Total Marrow and Lymphoid Irradiation
DRUG: Fenretinide
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
DRUG: Calaspargase Pegol
DRUG: Cytarabine
PROCEDURE: Echocardiography
DRUG: Fludarabine Phosphate
DRUG: Hydrocortisone Sodium Succinate
PROCEDURE: Lumbar Puncture
DRUG: Methotrexate
PROCEDURE: Multigated Acquisition Scan
DRUG: Prednisolone
DRUG: Prednisone
DRUG: Revumenib
DRUG: Vincristine Sulfate
DRUG: CTO1681 10 μg
DRUG: CTO1681 20 μg
DRUG: CTO1681 30 μg
DRUG: MT-601
GENETIC: CAR T Cells
BIOLOGICAL: Blinatumomab
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Pembrolizumab
DRUG: Methotrexate
DRUG: pralatraxate,
DRUG: Ifosfamide
DRUG: Dexamethasone
DRUG: Etoposide
DRUG: calaspargase pegol
DRUG: cyclophosphamide
DRUG: Doxorubicin
DRUG: Prednisone
DRUG: Brentuximab Vedotin
BIOLOGICAL: Peripheral Blood Stem Cell Transplant
DRUG: Allopurinol 300 MG
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: Bone Marrow Cell Transplant
RADIATION: Total Body Irradiation
DRUG: Sirolimus Pill
DRUG: Mycophenolate Mofetil
BIOLOGICAL: ATLCAR.CD30 cells
DRUG: Belinostat
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
OTHER: Pharmacokinetic Study
PROCEDURE: Positron Emission Tomography and Computed Tomography Scan
DRUG: Tazemetostat
DRUG: Conditioning Chemotherapy
BIOLOGICAL: Cord blood graft
PROCEDURE: Extracorporeal Photopheresis
BIOLOGICAL: Mogamulizumab
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
DRUG: E7777
DRUG: Daratumumab / Hyaluronidase Injection
DRUG: Daratumumab / Hyaluronidase Injection
DRUG: Daratumumab / Hyaluronidase Injection
DRUG: Daratumumab / Hyaluronidase Injection
BIOLOGICAL: Autologous Anti-CD19 CAR-expressing T-lymphocytes IC19/1563
DRUG: Bendamustine
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Fludarabine
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Fully human anti CD19 CAR-T Cell Dose
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Ruxolitinib
DRUG: Venetoclax
DRUG: Dexamethasone
DRUG: Inotuzumab Ozogamicin
DRUG: CM4620
DRUG: Pembrolizumab
DRUG: Pralatrexate
DRUG: Decitabine
DRUG: BET Bromodomain Inhibitor ZEN-3694
PROCEDURE: Core Biopsy
DRUG: Entinostat
DIETARY_SUPPLEMENT: Nicotinamide Riboside
DIETARY_SUPPLEMENT: Placebo
OTHER: Exercise Intervention
BIOLOGICAL: UCART22
BIOLOGICAL: CLLS52
BIOLOGICAL: CAR-20/19-T cells (5 x 10^5 CAR-20/19-T cells/kg)
BIOLOGICAL: CAR-20/19-T cells (1 x10^6 CAR-20/19-T cells/kg)
BIOLOGICAL: CAR-20/19-T cells (2.5 x10^6 CAR-20/19-T cells/kg)
BIOLOGICAL: CAR-20/19-T cells
BIOLOGICAL: Inotuzumab Ozogamicin
DRUG: Calaspargase pegol (S95015)
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
RADIATION: Radiation Therapy
BIOLOGICAL: Blinatumomab
DRUG: Ibrutinib
BIOLOGICAL: MABEL CTLs
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: CD19/CD22 CAR T-Cells
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: EB103
DRUG: Itacitinib
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Daunorubicin Hydrochloride
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Pegaspargase
DRUG: Prednisone
DRUG: Venetoclax
DRUG: Vincristine Sulfate
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: Lisocabtagene Maraleucel
DRUG: Polymer-conjugated IL-15 Receptor Agonist NKTR-255
PROCEDURE: X-Ray Imaging
PROCEDURE: Echocardiography
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Lumbar Puncture
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
PROCEDURE: Biospecimen Collection
PROCEDURE: Biopsy
GENETIC: CD7.CAR/28zeta CAR T cells
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: ACE1831
DRUG: Obinutuzumab
DRUG: Chimeric Antigen Receptor (CAR) T-Cell Product (Autologous)
DRUG: Ruxolitinib
DRUG: Asparaginase Erwinia chrysanthemi
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
DRUG: Calaspargase Pegol
DRUG: Cyclophosphamide
DRUG: Cytarabine
PROCEDURE: Diagnostic Imaging
BIOLOGICAL: Inotuzumab Ozogamicin
DRUG: Leucovorin Calcium
PROCEDURE: Lumbar Puncture
DRUG: Methotrexate
DRUG: Pegaspargase
DRUG: Vincristine
DRUG: Blinatumomab
DRUG: Asciminib
DRUG: Acalabrutinib
BIOLOGICAL: Axicabtagene Ciloleucel
DRUG: Busulfan
DRUG: Busulfan
DRUG: Fludarabine
RADIATION: Total-body irradiation
DRUG: Cyclophosphamide
DRUG: Melphalan
PROCEDURE: PBSC Hematopoietic Stem Cell Transplantation (HSCT)
PROCEDURE: Bone Marrow Hematopoietic Stem Cell Transplantation
DRUG: Post-transplant Cyclophosphamide
DRUG: Mesna
DRUG: Tacrolimus
DRUG: Mycophenolate Mofetil
OTHER: Patient-Reported Outcomes
BIOLOGICAL: Anti-CD19/CD20/CD22 CAR T-Cells
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
DRUG: Carboplatin
PROCEDURE: Computed Tomography
DRUG: Etoposide
DRUG: Ifosfamide
DRUG: Lenalidomide
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Tafasitamab
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
DRUG: Busulfan
DRUG: Cyclophosphamide
PROCEDURE: Echocardiography
DRUG: Fludarabine
PROCEDURE: Haploidentical Hematopoietic Cell Transplantation
BIOLOGICAL: Lapine T-Lymphocyte Immune Globulin
PROCEDURE: Lumbar Puncture
PROCEDURE: Matched Unrelated Donor Hematopoietic Cell Transplantation
DRUG: Melphalan
DRUG: Methotrexate
PROCEDURE: Multigated Acquisition Scan
DRUG: Mycophenolate Mofetil
PROCEDURE: Myeloablative Conditioning
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
BIOLOGICAL: Rituximab
PROCEDURE: T-Cell Depletion Therapy
DRUG: Tacrolimus
DRUG: Thiotepa
RADIATION: Total-Body Irradiation
BIOLOGICAL: NKX019
DRUG: MRX-2843
DRUG: Busulfan
DRUG: Fludarabine
PROCEDURE: PBSC Hematopoietic Stem Cell Transplantation (HSCT)
DRUG: Post-Transplant Cyclophosphamide
DRUG: Mesna
DRUG: Tacrolimus
DRUG: Mycophenolate Mofetil
OTHER: Patient Reported Outcomes
DRUG: Melphalan
RADIATION: Total-body irradiation
DRUG: Cyclophosphamide
BIOLOGICAL: Axicabtagene Ciloleucel
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: Lisocabtagene Maraleucel
BIOLOGICAL: Mosunetuzumab
OTHER: Patient Observation
DRUG: Polatuzumab Vedotin
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Tisagenlecleucel
DRUG: SAR443579
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Bone Scan
DRUG: Calaspargase Pegol
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Daunorubicin Hydrochloride
DRUG: Dexamethasone
DRUG: Doxorubicin Hydrochloride
BIOLOGICAL: Inotuzumab Ozogamicin
DRUG: Leucovorin Calcium
PROCEDURE: Magnetic Resonance Imaging
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Pegaspargase
PROCEDURE: Positron Emission Tomography
DRUG: Prednisolone
OTHER: Questionnaire Administration
RADIATION: Radiation Therapy
RADIATION: Radiation Therapy
DRUG: Thioguanine
DRUG: Vincristine Sulfate
DIETARY_SUPPLEMENT: Cholecalciferol
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Autologous BAFFR-targeting CAR T Cells
DRUG: Bendamustine
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
PROCEDURE: Echocardiography
DRUG: Fludarabine
PROCEDURE: Leukapheresis
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
DRUG: Dexamethasone
DRUG: Mitoxantrone
DRUG: PEG asparaginase
DRUG: Bortezomib
DRUG: Vorinostat
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Blinatumomab
DRUG: Ziftomenib
DRUG: Cyclophosphamide injection
DRUG: Fludarabine Injection
BIOLOGICAL: CD19-CD34t metabolically programmed CAR transduced T-cells
DRUG: Hypericin
OTHER: Visible Light
DRUG: Decitabine
DRUG: Dexamethasone
DRUG: Palbociclib
DRUG: Sorafenib
RADIATION: Total-Body Irradiation
DRUG: Thiotepa
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Busulfan
PROCEDURE: Allogeneic Bone Marrow Transplantation
DRUG: Tacrolimus
DRUG: Methotrexate
PROCEDURE: Naive T Cell-Depleted Hematopoietic Stem Cell Transplantation
PROCEDURE: Echocardiography
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
GENETIC: KUR-502
BIOLOGICAL: iC9-CAR19 cells
DRUG: Rimiducid
DRUG: Cyclophosphamide
DRUG: Fludarabine
GENETIC: CD19.CAR-aNKT cells
BIOLOGICAL: Anti-Thymocyte Globulin
DRUG: Cyclophosphamide
BIOLOGICAL: Cytokine-treated Veto Cells
DRUG: Fludarabine
PROCEDURE: Peripheral Blood Stem Cell Transplantation
RADIATION: Total-Body Irradiation
BIOLOGICAL: Autologous, humanized anti-CD22 CAR T cell therapy (CART22-65s)
BIOLOGICAL: Autologous, humanized anti-CD19 CAR T cell therapy (huCART19)
DRUG: CD22CART Infusion
BIOLOGICAL: CD19/CD22-CAR-transduced T cells
DRUG: cyclophosphamide
DRUG: fludarabine
DRUG: Imiquimod
RADIATION: Radiation Therapy
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Etoposide
DRUG: Prednisone
BIOLOGICAL: Rituximab
BIOLOGICAL: Tafasitamab
DRUG: Vincristine
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Lumbar Puncture
PROCEDURE: Biospecimen Collection
BIOLOGICAL: Azer-cel
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: IL-2
DRUG: Bendamustine
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
BIOLOGICAL: CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes
BIOLOGICAL: Cetuximab
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
PROCEDURE: Echocardiography
DRUG: Fludarabine
PROCEDURE: Leukapheresis
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Tisagenlecleucel
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
DRUG: Cyclophosphamide
DRUG: Cyclosporine
BIOLOGICAL: Filgrastim
DRUG: Fludarabine
DRUG: Mycophenolate Mofetil
DRUG: Mycophenolate Sodium
RADIATION: Total-Body Irradiation
DRUG: Treosulfan
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Echocardiography
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Dose Level 1A: 2 x 10^7 cells/m2
BIOLOGICAL: Dose Level 2A: 6 x 10^7 cells/m2
BIOLOGICAL: Dose Level 2B: 6 x 10^7 cells/m2
BIOLOGICAL: Dose Level 3B: 2 x 10^8 cells/m2
BIOLOGICAL: Dose Level 3A: 2 x 10^8 cells/m2
DRUG: N-Acetylcysteine
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Fludarabine Phosphate
BIOLOGICAL: Granulocyte Colony-Stimulating Factor
PROCEDURE: Hematopoietic Cell Transplantation
PROCEDURE: Intensity-Modulated Radiation Therapy
DRUG: Mycophenolate Mofetil
DRUG: Tacrolimus
DRUG: Brentuximab vedotin
DRUG: Pembrolizumab
GENETIC: Dose Level 1, VNX-101
GENETIC: Dose Level 2, VNX-101
GENETIC: Dose Level 3, VNX-101
GENETIC: Dose Level 4, VNX-101
DRUG: ATA3219
BIOLOGICAL: iC9-CAR19 T cells
DRUG: Bendamustine
DRUG: Fludarabine
DRUG: AP1903
DRUG: Cyclophosphamide
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: KITE-363
BIOLOGICAL: KITE-753
BIOLOGICAL: Zilovertamab vedotin
DRUG: Efineptakin alfa
DRUG: Tisagenlecleucel
DRUG: Axicabtagene ciloleucel
DRUG: Lisocabtagene Maraleucel
BIOLOGICAL: Allogeneic Natural Killer Cell Line NK-92
BIOLOGICAL: Anti-Thymocyte Globulin
DRUG: Busulfan
DRUG: Clofarabine
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
OTHER: Laboratory Biomarker Analysis
DRUG: Melphalan
BIOLOGICAL: Rituximab
RADIATION: Total-Body Irradiation
PROCEDURE: Umbilical Cord Blood Transplantation
DRUG: Dasatinib
DRUG: Methotrexate
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Venetoclax
BIOLOGICAL: Blinatumomab
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Lumbar Puncture
PROCEDURE: Biospecimen Collection
DRUG: Venetoclax
DRUG: Azacitidine
DRUG: Cytarabine
DRUG: Methotrexate
DRUG: Hydrocortisone
DRUG: Leucovorin
DRUG: Dexamethasone
DRUG: Vincristine
DRUG: Doxorubicin
DRUG: Dexrazoxane
DRUG: Calaspargase Pegol
DRUG: Erwinia asparaginase
DRUG: Chemotherapy
BIOLOGICAL: Cell infusion
GENETIC: ALLO-501A
BIOLOGICAL: ALLO-647
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: SCRI-CAR22v2
BIOLOGICAL: Blinatumomab
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Doxorubicin Hydrochloride
BIOLOGICAL: Inotuzumab Ozogamicin
OTHER: Laboratory Biomarker Analysis
DRUG: Mercaptopurine
DRUG: Methotrexate
BIOLOGICAL: Ofatumumab
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Vincristine Sulfate
DEVICE: CliniMACS
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: Mogamulizumab
BIOLOGICAL: Natural Killer Cell Therapy
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration
DRUG: Ruxolitinib
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Mercaptopurine
DRUG: Vincristine
DRUG: Pegaspargase
DRUG: Rituximab
DRUG: Methotrexate (Intrathecal Administration)
DRUG: Methotrexate (Intravenous Administration)
DRUG: Dexamethasone
DRUG: Doxorubicin
DRUG: Thioguanine
DRUG: Methotrexate Oral Product
DRUG: SC291
BIOLOGICAL: Pneumococcal conjugate vaccine (PCV13)
BIOLOGICAL: CD19 targeted CAR T Cell Therapy
DRUG: Inotuzumab ozogamicin
DRUG: Methotrexate
DRUG: Hydrocortisone
DRUG: Cytarabine
DRUG: Diphenhydramine
DRUG: Acetaminophen
DRUG: Methylprednisolone
PROCEDURE: Biospecimen Collection
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: Oral Azacitidine
DRUG: Prednisone
OTHER: Questionnaire Administration
BIOLOGICAL: Rituximab
DRUG: Vincristine Sulfate
DRUG: Etoposide
DRUG: BCNU
DRUG: AraC
DRUG: Melphalan
PROCEDURE: Peripheral blood stem cell transplantation
BIOLOGICAL: G-CSF
DRUG: Cyclophosphamide
RADIATION: Total Body Irradiation
DRUG: Tagraxofusp
DRUG: Fludarabine
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Vincristine
DRUG: Azacitidine
DRUG: Methotrexate
DRUG: Cytarabine IT
DRUG: Hydrocortisone
BIOLOGICAL: CTX112
BIOLOGICAL: Murine CART19
BIOLOGICAL: 19(T2)28z1xx TRAC T cell
DRUG: TURALIO(R)
BIOLOGICAL: ADCT-602
DRUG: Daratumumab
DRUG: revumenib
DRUG: cobicistat
PROCEDURE: Haploidentical Bone Marrow/Kidney
DRUG: TAB004
DRUG: Toripalimab
DRUG: AFM13
DRUG: AB-101
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Interleukin-2
DRUG: ACALABRUTINIB
DRUG: LISOCABTAGENE MARALEUCEL
DRUG: Lymphodepleting chemotherapy
DRUG: Dasatinib
BIOLOGICAL: Autologous Humanized CD19-Directed Chimeric Antigen Receptor T-Cells (huCART19)
DRUG: Duvelisib
BIOLOGICAL: Tisagenlecleucel
DRUG: Fludarabine
DRUG: Cyclophosphamide
RADIATION: Total Body Irradiation
DRUG: Cyclosporine A
DRUG: Mycophenylate mofetil
BIOLOGICAL: Umbilical cord blood
DRUG: APG-115
DRUG: APG-2575
DRUG: Tecartus
DRUG: NKTR-255 at 1.5 µg/kg
DRUG: NKTR-255 at 3.0 μg/kg
DRUG: NKTR-255 at 3.0/6.0 μg/kg
OTHER: Placebo Comparator
DRUG: Pembrolizumab
DRUG: Mogamulizumab
DRUG: Blinatumomab
DRUG: Low-intensity chemotherapy regimen
DRUG: SOC chemotherapy regimen
DEVICE: CliniMACS Cell Processing System for TCRαβ + T Cell and CD45RA Depleted Peripheral Stem Cell Addback
DRUG: Siltuximab
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Echocardiography
BIOLOGICAL: Pembrolizumab
PROCEDURE: Positron Emission Tomography
DRUG: Tazemetostat
DRUG: Fludarabine
DRUG: Busulfan
DRUG: Melphalan
DRUG: Rituximab
DRUG: Levetiracetam
DRUG: JNJ-90009530
DRUG: LP-118
DRUG: Ponatinib
DRUG: Vincristine
DRUG: Dexamethasone
DRUG: Methotrexate
DRUG: DSP-5336
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: PRGN-3007
DRUG: ARV-393
DRUG: Tazemetostat Pill
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspirate
DRUG: Cyclophosphamide
DRUG: Cyclosporine
PROCEDURE: Diagnostic Imaging
PROCEDURE: Echocardiography
DRUG: Fludarabine Phosphate
PROCEDURE: Multigated Acquisition Scan
DRUG: Mycophenolate Mofetil
OTHER: Survey Administration
DRUG: Thiotepa
RADIATION: Total-Body Irradiation
PROCEDURE: Umbilical Cord Blood Transplantation
BIOLOGICAL: Cohort 1
BIOLOGICAL: Cohorts 2
BIOLOGICAL: Cohort 3
RADIATION: Bridging radiotherapy (BRT)
DRUG: Conditioning chemotherapy
BIOLOGICAL: CAR T-cell product
DRUG: Blinatumomab
BIOLOGICAL: BEAM-201
DRUG: CD79b-19 CAR T cells
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: CD19x22 CAR T Cells
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Golcadomide
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Rituximab
DRUG: SGR-1505
DRUG: Gemcitabine
DRUG: Pembrolizumab
DRUG: AZD0486
DRUG: Itacitinib
BIOLOGICAL: Chimeric antigen receptor (CAR) T-cell therapy
DRUG: Azacytidine
DRUG: Romidepsin
DRUG: Belinostat
DRUG: Pralatrexate
DRUG: Gemcitabine
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Blinatumomab
DRUG: Methotrexate
DRUG: Cytarabine
DRUG: Mercaptopurine
DRUG: Prednisone
DRUG: Pegfilgrastim
DRUG: Inotuzumab ozogamicin
DRUG: Rituximab
DRUG: Dexamethasone
BIOLOGICAL: AUTO1
BIOLOGICAL: Anti-CD19-CAR CMV-specific T-lymphocytes
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Leukapheresis
PROCEDURE: Lymphodepletion Therapy
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
PROCEDURE: Positron Emission Tomography
PROCEDURE: X-Ray Imaging
DRUG: Loncastuximab Tesirine
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Ontorpacept
BIOLOGICAL: Pembrolizumab
PROCEDURE: Positron Emission Tomography
DRUG: Maplirpacept
PROCEDURE: Biopsy
DRUG: Mogamulizumab
RADIATION: LD TSEBT
DRUG: Fludarabine
OTHER: Laboratory Biomarker Analysis
DRUG: Melphalan
RADIATION: Total Marrow Irradiation
BIOLOGICAL: Orca-Q
BIOLOGICAL: Autologous HuCD19 ( Anti-CD19)CAR T cells
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Rituximab
DRUG: Inotuzumab ozogamicin
DRUG: Dasatinib
DRUG: Dexamethasone
DRUG: Methotrexate
DRUG: Vincristine
DRUG: Ponatinib
DRUG: Methotrexate for Injection
PROCEDURE: Allogenic Stem Cell Transplantation
GENETIC: Autologous CD5.CAR/28zeta CAR T cells
GENETIC: Allogeneic CD5.CAR/28zeta CAR T cells
DRUG: Acalabrutinib
BIOLOGICAL: CD19CAR-CD28-CD3zeta-EGFRt-expressing Tn/mem-enriched T-lymphocytes
DEVICE: Miltenyi CliniMACS Prodigy ® system
DRUG: SGN-35C
DRUG: Mogamulizumab-Kpkc
DEVICE: Phototherapy
BIOLOGICAL: OrcaGraft (Orca-Q)
DRUG: Relatlimab
DRUG: Nivolumab
DRUG: BAFF CAR-T
DRUG: SGN-35T
BIOLOGICAL: CTX131
BIOLOGICAL: autologous hematopoietic stem cells added to planned CAR T
DEVICE: Alpha Beta T cell depletion
DRUG: Azacitidine
DRUG: Venetoclax
BIOLOGICAL: CD19-CAR(Mem) T-cells
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Mesna
DEVICE: CliniMACS
PROCEDURE: Leukapheresis
BIOLOGICAL: CD4CAR
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
BIOLOGICAL: Basiliximab
DRUG: Fludarabine Phosphate
DRUG: Indium In 111-DOTA-Basiliximab
DRUG: Melphalan
BIOLOGICAL: Palifermin
RADIATION: Total Lymphoid Irradiation
RADIATION: Total Marrow Irradiation
BIOLOGICAL: Yttrium Y 90 Basiliximab
DRUG: LP-118
OTHER: Pharmacokinetics
OTHER: Pharmacokinetics
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
OTHER: Laboratory Biomarker Analysis
OTHER: Questionnaire Administration
DRUG: Cyclophosphamide
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Prednisone
DRUG: Etoposide
DRUG: Duvelisib
DRUG: Oral azacitidine
RADIATION: Adaptive Bridging Radiation Therapy (ABRT)
BIOLOGICAL: Blinatumomab
DRUG: Cytarabine
DRUG: Methotrexate
DRUG: Ponatinib
BIOLOGICAL: Blinatumomab
BIOLOGICAL: Inotuzumab Ozogamicin
DRUG: Bortezomib
DRUG: Clofarabine
DRUG: Cyclophosphamide
DRUG: Dexamethasone
DRUG: Etoposide
BIOLOGICAL: Ofatumumab
BIOLOGICAL: Pegfilgrastim
BIOLOGICAL: Rituximab
DRUG: Vincristine Sulfate Liposome
BIOLOGICAL: BAFFR-CAR T cells
BIOLOGICAL: ATLCAR.CD30 T cells
DRUG: Bendamustine
DRUG: Fludarabine
DRUG: Cyclophosphamide
OTHER: Ossium HPC Marrow, Bone Marrow Transplant
OTHER: Pre-transplant conditioning - Myeloablative (MAC)
OTHER: Pre-transplant conditioning - Reduced Intensity (RIC)
OTHER: Post-transplant treatment
RADIATION: Total-Body Irradiation
DRUG: Thiotepa
DRUG: Fludarabine
DRUG: Tacrolimus
BIOLOGICAL: Allogeneic CD34+-enriched and CD45RA-depleted PBSCs
DRUG: Methotrexate
DRUG: Cyclophosphamide
BIOLOGICAL: Peripheral Blood Stem Cell
DRUG: Cyclosporine
DRUG: Sirolimus
DRUG: Busulfan
PROCEDURE: Bone Marrow Aspiration and Biopsy
PROCEDURE: Echocardiography
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Biospecimen Collection
DRUG: DPX-Survivac
DRUG: Pembrolizumab
DRUG: CPA
BIOLOGICAL: PIT565
DRUG: 131-I Apamistamab
BIOLOGICAL: CAR T-cell
PROCEDURE: Allogeneic Bone Marrow Transplantation
DRUG: Bendamustine
BIOLOGICAL: Filgrastim-sndz
DRUG: Fludarabine
BIOLOGICAL: Inotuzumab Ozogamicin
DRUG: Melphalan
PROCEDURE: Peripheral Blood Stem Cell Transplantation
BIOLOGICAL: Rituximab
DRUG: Tacrolimus
DRUG: ABL001
DRUG: Dasatinib
DRUG: Prednisone
DRUG: Blinatumomab
DRUG: EAGD T-cell infusion (Phase I)
DRUG: EAGD T-cell infusion (Expansion)
DRUG: mosunetuzumab
DRUG: glofitamab
DRUG: obinutuzumab
DRUG: ATL-RIC
DRUG: mRIC
PROCEDURE: allo HCT
DRUG: RIC
DRUG: GVHD prophylaxis
DRUG: IOC
DRUG: AKR1C3-activated Prodrug OBI-3424
DRUG: STP938
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: CD70-CAR T cell infusion (Autologous)
DRUG: Mesna
DRUG: Ritlecitinib
DRUG: Nanatinostat in combination with valganciclovir
DRUG: IMPT-314
DRUG: L-Bcl-2 antisense oligonucleotide
BIOLOGICAL: BAFFR-CAR T cells
GENETIC: CB-010
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: huCART19-IL18
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter
PROCEDURE: Single Photon Emission Computed Tomography
BIOLOGICAL: Cemiplimab
BIOLOGICAL: Ipilimumab
BIOLOGICAL: tabelecleucel
DRUG: CAR.k.28
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Bendamustine
DRUG: Soquelitinib
DRUG: Belinostat
DRUG: Pralatrexate
DRUG: Hyper CVAD Protocol (Standard of Care Multi-Agent Chemotherapy)
DRUG: Calaspargase Pegol
DRUG: Rituximab
DRUG: BMF-219
DRUG: UVADEX® (methoxsalen) Sterile Solution in conjunction with the THERAKOS® CELLEX Photopheresis
DEVICE: THERAKOS® CELLEX photopheresis system
BIOLOGICAL: Anti-CD19-CAR CMV-specific T-lymphocytes
PROCEDURE: Autologous Hematopoietic Stem Cell Transplantation
BIOLOGICAL: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
PROCEDURE: Myeloablative Conditioning
BIOLOGICAL: JNJ-90014496
BIOLOGICAL: Blinatumomab
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dexamethasone
BIOLOGICAL: Inotuzumab Ozogamicin
OTHER: Laboratory Biomarker Analysis
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Prednisone
BIOLOGICAL: Rituximab
DRUG: Vincristine
DRUG: PRT2527
DRUG: Zanubrutinib
DRUG: Venetoclax
DRUG: DR-01
BIOLOGICAL: CD30.CAR-EBVST cells
DRUG: Epcoritamab
DRUG: CD19 Directed CAR T Cell
BIOLOGICAL: TmCD19-IL18
DRUG: Venetoclax
DRUG: Standard Chemotherapy
DRUG: ABBV-101
DRUG: Bexarotene
RADIATION: Total Skin Electron Beam (TSEB)
DRUG: Siltuximab
DRUG: Akt/ERK Inhibitor ONC201
BIOLOGICAL: Rapcabtagene autoleucel single agent
DRUG: Ibrutinib
DEVICE: Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
DRUG: brentuximab vedotin
DRUG: brentuximab vedotin
DRUG: brentuximab vedotin
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: Etoposide
DRUG: Lenalidomide
PROCEDURE: Positron Emission Tomography
DRUG: Prednisone
DRUG: Vincristine Sulfate
DRUG: Palbociclib
DRUG: Dexamethasone
DRUG: Bortezomib
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Dexamethasone
BIOLOGICAL: Inotuzumab Ozogamicin
DRUG: Methotrexate
DRUG: Cytarabine
DRUG: Methylprednisolone
BIOLOGICAL: Rituximab
DRUG: Prednisone
DRUG: Mercaptopurine
DRUG: Doxorubicin
DRUG: CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
DRUG: Cyclophosphamide
DRUG: Fludarabine Phosphate
BIOLOGICAL: Tocilizumab
DRUG: CD22CART infusion
DRUG: Tisagenlecleucel
DRUG: etoposide
DRUG: cyclophosphamide
RADIATION: total marrow irradiation
PROCEDURE: allogeneic hematopoietic stem cell transplantation
PROCEDURE: allogeneic bone marrow transplantation
DRUG: Tulmimetostat
DRUG: SYNCAR-001
DRUG: STK-009
DRUG: Cyclophosphamide
DRUG: Fludarabine
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
PROCEDURE: Biospecimen Collection
DRUG: Granulocyte Colony-Stimulating Factor
DRUG: Hematopoietic Cell Transplantation Conditioning Regimen
BIOLOGICAL: Multi-peptide CMV-Modified Vaccinia Ankara Vaccine
PROCEDURE: Pheresis
DRUG: Placebo Administration
DRUG: Stem Cell Mobilization Therapy
DRUG: Inotuzumab Ozogamicin
PROCEDURE: Aspiration
PROCEDURE: Biospecimen Collection
PROCEDURE: Catheterization
BIOLOGICAL: CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T-lymphocytes
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Fludarabine
PROCEDURE: Leukapheresis
PROCEDURE: Lumbar Puncture
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Duvelisib
BIOLOGICAL: Nivolumab
PROCEDURE: Positron Emission Tomography
PROCEDURE: Punch Biopsy
DRUG: Bleximenib
DRUG: Belantamab Mafodotin
RADIATION: Comprehensive Ablative Bridging Irradiation (CABI)
BIOLOGICAL: Chimeric Antigen Receptor T-Cell Therapy
OTHER: Laboratory Biomarker Analysis
DRUG: Venetoclax
DRUG: Vincristine Liposomal
DRUG: BMF-500
DRUG: 1A46 Injection
DRUG: Senza5 CART5
DRUG: Blinatumomab
DRUG: Inotuzumab Ozogamicin
DRUG: Hyper-CVAD
DRUG: Mini-hyper-CVD
BIOLOGICAL: P-CD19CD20-ALLO1
DRUG: Rimiducid
DRUG: SC262
DRUG: Autologous Anti-CD19 CAR-expressing T Lymphocytes
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration and Biopsy
DRUG: Cyclophosphamide
DRUG: Fludarabine
PROCEDURE: Leukapheresis
OTHER: Questionnaire Administration
DRUG: Vactosertib
DRUG: Fludarabine Phosphate
DRUG: Cyclophosphamide
DRUG: IL-2
DRUG: Natural Killer Cells
DRUG: Ascentage Pharma HQP1351 bioavailable inhibitor
DRUG: Blinatumomab
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
BIOLOGICAL: Epcoritamab
PROCEDURE: Magnetic Resonance Imaging
OTHER: Patient Observation
PROCEDURE: Positron Emission Tomography
DRUG: Pembrolizumab
DRUG: Lymphodepletion Chemotherapy
DRUG: Chimeric Antigen Receptor (CAR) Therapy Infusion
PROCEDURE: Leukapheresis
PROCEDURE: Biospecimen Collection
BIOLOGICAL: Blinatumomab
PROCEDURE: Bone Marrow Aspiration and Biopsy
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dasatinib
DRUG: Dexamethasone
DRUG: Doxorubicin Hydrochloride
PROCEDURE: Echocardiography
PROCEDURE: Electrocardiography
PROCEDURE: Lumbar Puncture
DRUG: Mesna
DRUG: Methotrexate
PROCEDURE: Multigated Acquisition Scan
DRUG: Ponatinib Hydrochloride
DRUG: Prednisone
DRUG: Vincristine Sulfate
DRUG: JNJ-80948543
DRUG: Duvelisib
DRUG: Mosunetuzumab
DRUG: Polatuzumab
BIOLOGICAL: CAR-T Cell Therapy
DRUG: SIM1811-03
BIOLOGICAL: SynKIR-310
BIOLOGICAL: HSCT with TBI Regimen
BIOLOGICAL: HSCT with Non-TBI Regimen
DRUG: NX-1607
DRUG: Paclitaxel
BIOLOGICAL: 8/12-Day Production of Car-T Cells
BIOLOGICAL: 8/12-Day Production of Cryopreserved Car-T Cells
BIOLOGICAL: 12-Day Production of Car-T Cells
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter
PROCEDURE: Single Photon Emission Computed Tomography
BIOLOGICAL: Cemiplimab
DRUG: alpha beta depletion
DRUG: Tazemetostat
DRUG: Darzalex Faspro (Daratumumab and hyaluronidase-fihj)
DEVICE: JH-DSA Semi-Quant Screen and Response Score
BIOLOGICAL: Anti-CD19 CAR-T cells
DRUG: Obinutuzumab
DRUG: Liposomal ARA-C
DRUG: Ifosfamide
DRUG: Carboplatin
DRUG: Etoposide
BIOLOGICAL: ATLCAR.CD30.CCR4 cells
BIOLOGICAL: ALTCAR.CD30 cells
DRUG: Bendamustine
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Cytarabine
DRUG: Dexamethasone
DRUG: Doxorubicin Hydrochloride
DRUG: Mercaptopurine
DRUG: Methotrexate
DRUG: Nelarabine
DRUG: Pegaspargase
DRUG: Prednisone
DRUG: Venetoclax
DRUG: Vincristine Sulfate
DRUG: Fludarabine Phosphate
DRUG: Melphalan
RADIATION: Intensity-Modulated Radiation Therapy
RADIATION: Total Marrow Irradiation
PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
PROCEDURE: Peripheral Blood Stem Cell Transplantation
PROCEDURE: Allogeneic Bone Marrow Transplantation
DRUG: Tacrolimus
DRUG: Mycophenolate Mofetil
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: bbT369
DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: anti-CD19 CAR-T cells
GENETIC: cemacabtagene ansegedleucel
BIOLOGICAL: ALLO-647
DRUG: Fludarabine
DRUG: Cyclophosphamide
DEVICE: Foresight CLARITY™ IUO MRD test, powered by PhasED-Seq™
BIOLOGICAL: UCART20x22
BIOLOGICAL: CLLS52
DRUG: Fludarabine (Conditional therapy)
DRUG: Cyclophosphamide Monohydrate (Conditional therapy)
DRUG: firi-cel (Experimental drug)
BIOLOGICAL: Axicabtagene Ciloleucel
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: CPI-0209
RADIATION: Focal radiation therapy (RT)
DRUG: Belinostat Injection
DRUG: Pralatrexate Injection
DRUG: CHOP
DRUG: COP
BIOLOGICAL: Dilanubicel
DRUG: Cyclophosphamide
DRUG: Fludarabine
DRUG: Thiotepa
RADIATION: Total-Body Irradiation
PROCEDURE: Umbilical Cord Blood Transplantation
OTHER: Laboratory Biomarker Analysis
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspirate
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Electrocardiography
PROCEDURE: Computed Tomography
DRUG: Oral Azacitidine
GENETIC: Dose Escalation Phase:CD19.CAR/28 and CD19.CAR/28137 T cells
GENETIC: Expansion Phase: CD19.CAR/28 and CD19.CAR/28137 T cells
DRUG: Allogeneic donor-derived T-cells transduced with bivalent lentiviral vector (CD19/CD22-BBz) chimeric antigen receptor (CAR)
DRUG: Treg CD34+HSPC (Orca-T)
DRUG: Brentuximab vedotin
PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
PROCEDURE: Echocardiography
BIOLOGICAL: EGFRt/19-28z/IL-12 CAR T-lymphocytes
DRUG: Fludarabine Phosphate
PROCEDURE: Leukapheresis
PROCEDURE: Multigated Acquisition Scan
PROCEDURE: Positron Emission Tomography
BIOLOGICAL: Kappa CD28 T cells
DRUG: Blinatumomab
Get the latest thought leadership on your Hodgkin Lymphoma delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.